261 related articles for article (PubMed ID: 16541021)
1. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
Chen YM; Lin SL; Chiang WC; Wu KD; Tsai TJ
Kidney Int; 2006 Apr; 69(8):1410-5. PubMed ID: 16541021
[TBL] [Abstract][Full Text] [Related]
2. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
4. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
6. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
Chanrat E; Worawichawong S; Radinahamed P; Sathirapongsasuti N; Nongnuch A; Assanatham M; Udomsubpayakul U; Kitiyakara C
Cytokine; 2018 Apr; 104():1-7. PubMed ID: 29414320
[TBL] [Abstract][Full Text] [Related]
7. Effect of pentoxifylline on graft function of renal transplant recipients complicated with chronic allograft nephropathy.
Shu KH; Wu MJ; Chen CH; Cheng CH; Lian JD; Lu YS
Clin Nephrol; 2007 Mar; 67(3):157-63. PubMed ID: 17390740
[TBL] [Abstract][Full Text] [Related]
8. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.
Ghorbani A; Omidvar B; Beladi-Mousavi SS; Lak E; Vaziri S
Nefrologia; 2012; 32(6):790-6. PubMed ID: 23169362
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Branten AJ; Klasen IS; Wetzels JF
Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
[TBL] [Abstract][Full Text] [Related]
10. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.
Quinkler M; Zehnder D; Eardley KS; Lepenies J; Howie AJ; Hughes SV; Cockwell P; Hewison M; Stewart PM
Circulation; 2005 Sep; 112(10):1435-43. PubMed ID: 16145013
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
Agarwal R
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemoattractant protein-1 levels in patients with glomerular disease.
Rovin BH; Doe N; Tan LC
Am J Kidney Dis; 1996 May; 27(5):640-6. PubMed ID: 8629622
[TBL] [Abstract][Full Text] [Related]
14. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
Wu CC; Chen JS; Lu KC; Chen CC; Lin SH; Chu P; Sytwu HK; Lin YF
Clin Chim Acta; 2010 May; 411(9-10):700-4. PubMed ID: 20138168
[TBL] [Abstract][Full Text] [Related]
15. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
16. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
Kalavrizioti D; Gerolymos M; Rodi M; Kalliakmani P; Provatopoulou S; Eleftheriadis T; Mouzaki A; Goumenos DS
Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557
[TBL] [Abstract][Full Text] [Related]
17. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration.
Navarro JF; Mora C; Rivero A; Gallego E; Chahin J; Macía M; Méndez ML; García J
Am J Kidney Dis; 1999 Mar; 33(3):458-63. PubMed ID: 10070909
[TBL] [Abstract][Full Text] [Related]
18. Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis.
Jiang X; Zhou S; Yao J; Kong X; Cui M
J Nephrol; 2016 Oct; 29(5):653-62. PubMed ID: 26510426
[TBL] [Abstract][Full Text] [Related]
19. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
[TBL] [Abstract][Full Text] [Related]
20. Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria.
Bakoush O; Grubb A; Rippe B; Tencer J
Kidney Int; 2001 Nov; 60(5):1904-9. PubMed ID: 11703609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
